The DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
IL-6 biology: implications for clinical targeting in rheumatic disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
The pro- and anti-inflammatory properties of the cytokine interleukin-6
Scheller, J., Chalaris, A., Schmidt-Arras, D., & Rose-John, S. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.01.034 · Cited by 3,212
Self-citationA metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells
Black, R. A., Rauch, C. T., Kozlosky, C. J., Peschon, J. J., Slack, J. L., Wolfson, M. F., Castner, B. J., Stocking, K. L., Reddy, P., Srinivasan, S., et al. (1997) · Nature · doi:10.1038/385729a0 · Cited by 3,149
Interleukin-6 and the acute phase response
Heinrich, P. C., Castell, J. V., & Andus, T. (1990) · Biochemical Journal · doi:10.1042/bj2650621 · Cited by 2,734
Grivennikov, S., Karin, E., Terzic, J., Mucida, D., Yu, G.-Y., Vallabhapurapu, S., Scheller, J., Rose-John, S., Cheroutre, H., Eckmann, L., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.001 · Cited by 2,155
Self-citationHirano, T., Yasukawa, K., Harada, H., Taga, T., Watanabe, Y., Matsuda, T., Kashiwamura, S.-I., Nakajima, K., Koyama, K., Iwamatsu, A., et al. (1986) · Nature · doi:10.1038/324073a0 · Cited by 2,139
An Essential Role for Ectodomain Shedding in Mammalian Development
Peschon, J. J., Slack, J. L., Reddy, P., Stocking, K. L., Sunnarborg, S. W., Lee, D. C., Russell, W. E., Castner, B. J., Johnson, R. S., Fitzner, J. N., et al. (1998) · Science · doi:10.1126/science.282.5392.1281 · Cited by 1,607
Atreya, R., Mudter, J., Finotto, S., Müllberg, J., Jostock, T., Wirtz, S., Schütz, M., Bartsch, B., Holtmann, M., Becker, C., et al. (2000) · Nature Medicine · doi:10.1038/75068 · Cited by 1,293
Self-citationJAK and STAT Signaling Molecules in Immunoregulation and Immune-Mediated Disease
O'Shea, J. J., & Plenge, R. (2012) · Immunity · doi:10.1016/j.immuni.2012.03.014 · Cited by 1,138
O'Shea, J. J., Gadina, M., & Schreiber, R. D. (2002) · Cell · doi:10.1016/s0092-8674(02)00701-8 · Cited by 1,119
Rose-John, S. (2012) · International Journal of Biological Sciences · doi:10.7150/ijbs.4989 · Cited by 1,040
Self-citationINTERLEUKIN-6: From Basic Science to Medicine—40 Years in Immunology
Kishimoto, T. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115806 · Cited by 1,024
Inflammatory bone loss: pathogenesis and therapeutic intervention
Redlich, K., & Smolen, J. S. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3669 · Cited by 830
Hurst, S. M., Wilkinson, T. S., McLoughlin, R. M., Jones, S., Horiuchi, S., Yamamoto, N., Rose-John, S., Fuller, G. M., Topley, N., & Jones, S. A. (2001) · Immunity · doi:10.1016/s1074-7613(01)00151-0 · Cited by 811
Self-citationSoluble receptors for cytokines and growth factors: generation and biological function
Rose-John, S., & Heinrich, P. C. (1994) · Biochemical Journal · doi:10.1042/bj3000281 · Cited by 775
Self-citationTGF-β Suppresses Tumor Progression in Colon Cancer by Inhibition of IL-6 trans-Signaling
Becker, C., Fantini, M. C., Schramm, C., Lehr, H. A., Wirtz, S., Nikolaev, A., Burg, J., Strand, S., Kiesslich, R., Huber, S., et al. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.020 · Cited by 726
Self-citationUpdated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
Furst, D. E., Keystone, E. C., Braun, J., Breedveld, F. C., Burmester, G. R., De Benedetti, F., Dörner, T., Emery, P., Fleischmann, R., Gibofsky, A., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.146852 · Cited by 687
Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling
Jones, S. A., Scheller, J., & Rose-John, S. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57158 · Cited by 683
Self-citationGabay, C., Emery, P., van Vollenhoven, R., Dikranian, A., Alten, R., Pavelka, K., Klearman, M., Musselman, D., Agarwal, S., Green, J., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60250-0 · Cited by 672
Soluble gp130 is the natural inhibitor of soluble interleukin‐6 receptor transsignaling responses
Jostock, T., Müllberg, J., Özbek, S., Atreya, R., Blinn, G., Voltz, N., Fischer, M., Neurath, M. F., & Rose‐John, S. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.01867.x · Cited by 641
Self-citationThe paradigm of IL-6: from basic science to medicine.
Naka, T., Nishimoto, N., & Kishimoto, T. (2002) · Arthritis Research · doi:10.1186/ar565 · Cited by 565
A bioactive designer cytokine for human hematopoietic progenitor cell expansion
Fischer, M., Goldschmitt, J., Peschel, C., Brakenhoff, J. P. G., Kallen, K.-J., Wollmer, A., Grötzinger, J., & Rose-John, S. (1997) · Nature Biotechnology · doi:10.1038/nbt0297-142 · Cited by 530
Self-citationADAM17: a molecular switch to control inflammation and tissue regeneration
Scheller, J., Chalaris, A., Garbers, C., & Rose-John, S. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.05.005 · Cited by 526
Self-citationKorn, T., Mitsdoerffer, M., Croxford, A. L., Awasthi, A., Dardalhon, V. A., Galileos, G., Vollmar, P., Stritesky, G. L., Kaplan, M. H., Waisman, A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809850105 · Cited by 508
Illei, G. G., Shirota, Y., Yarboro, C. H., Daruwalla, J., Tackey, E., Takada, K., Fleisher, T., Balow, J. E., & Lipsky, P. E. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27221 · Cited by 507
The soluble interleukin‐6 receptor is generated by shedding
Mülberg, J., Schooltink, H., Stoyan, T., Günther, M., Graeve, L., Buse, G., Mackiewicz, A., Heinrich, P. C., & Rose‐John, S. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230226 · Cited by 506
Self-citationBiologics for rheumatoid arthritis: an overview of Cochrane reviews
Singh, J. A., Christensen, R., Wells, G. A., Suarez-Almazor, M. E., Buchbinder, R., Lopez-Olivo, M. A., Ghogomu, E. T., & Tugwell, P. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007848.pub2 · Cited by 470
Immune mechanisms in medium and large-vessel vasculitis
Weyand, C. M., & Goronzy, J. J. (2013) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2013.161 · Cited by 412
Matthews, V., Schuster, B., Schütze, S., Bussmeyer, I., Ludwig, A., Hundhausen, C., Sadowski, T., Saftig, P., Hartmann, D., Kallen, K.-J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210584200 · Cited by 390
Self-citationIntegrated safety in tocilizumab clinical trials
Schiff, M. H., Kremer, J. M., Jahreis, A., Vernon, E., Isaacs, J. D., & van Vollenhoven, R. F. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3455 · Cited by 367
Lethal tuberculosis in interleukin-6-deficient mutant mice
Ladel, C. H., Blum, C., Dreher, A., Reifenberg, K., Kopf, M., & Kaufmann, S. H. (1997) · Infection and Immunity · doi:10.1128/iai.65.11.4843-4849.1997 · Cited by 358
Doganci, A., Eigenbrod, T., Krug, N., De Sanctis, G. T., Hausding, M., Erpenbeck, V. J., Haddad, E.-B., Schmitt, E., Bopp, T., Kallen, K.-J., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci22433 · Cited by 333
Self-citationSympathetic neurons can produce and respond to interleukin 6
März, P., Cheng, J.-G., Gadient, R. A., Patterson, P. H., Stoyan, T., Otten, U., & Rose-John, S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.3251 · Cited by 332
Self-citationChalaris, A., Rabe, B., Paliga, K., Lange, H., Laskay, T., Fielding, C. A., Jones, S. A., Rose-John, S., & Scheller, J. (2007) · Blood · doi:10.1182/blood-2007-01-067918 · Cited by 329
Self-citationMcInnes, I. B., Thompson, L., Giles, J. T., Bathon, J. M., Salmon, J. E., Beaulieu, A. D., Codding, C. E., Carlson, T. H., Delles, C., Lee, J. S., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204345 · Cited by 324
Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives
Kitas, G. D., & Gabriel, S. E. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.142133 · Cited by 321
Ferreira, R. C., Freitag, D. F., Cutler, A. J., Howson, J. M. M., Rainbow, D. B., Smyth, D. J., Kaptoge, S., Clarke, P., Boreham, C., Coulson, R. M., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003444 · Cited by 316
Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor
Lust, J. A., Donovan, K. A., Kline, M. P., Greipp, P. R., Kyle, R. A., & Maihle, N. J. (1992) · Cytokine · doi:10.1016/1043-4666(92)90043-q · Cited by 316
Interleukin-6: from basic biology to selective blockade of pro-inflammatory activities
Scheller, J., Garbers, C., & Rose-John, S. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2013.11.002 · Cited by 308
Self-citationDoganci, A., Eigenbrod, T., Krug, N., De Sanctis, G. T., Hausding, M., Erpenbeck, V. J., Haddad, E.-B., Schmitt, E., Bopp, T., Kallen, K.-J., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522433 · Cited by 304
Self-citationInterleukin-6 and its receptor: from bench to bedside
Scheller, J., & Rose-John, S. (2006) · Medical Microbiology and Immunology · doi:10.1007/s00430-006-0019-9 · Cited by 292
Self-citationIL-6 trans-signaling promotes pancreatitis-associated lung injury and lethality
Zhang, H., Neuhöfer, P., Song, L., Rabe, B., Lesina, M., Kurkowski, M. U., Treiber, M., Wartmann, T., Regnér, S., Thorlacius, H., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64931 · Cited by 288
Self-citationUnizony, S., Arias‐Urdaneta, L., Miloslavsky, E., Arvikar, S., Khosroshahi, A., Keroack, B., Stone, J. R., & Stone, J. H. (2012) · Arthritis Care & Research · doi:10.1002/acr.21750 · Cited by 272
Chalaris, A., Adam, N., Sina, C., Rosenstiel, P., Lehmann-Koch, J., Schirmacher, P., Hartmann, D., Cichy, J., Gavrilova, O., Schreiber, S., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20092366 · Cited by 269
Self-citationNowell, M. A., Richards, P. J., Horiuchi, S., Yamamoto, N., Rose-John, S., Topley, N., Williams, A. S., & Jones, S. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.6.3202 · Cited by 268
Self-citationChanges in lipid levels with inflammation and therapy in RA: a maturing paradigm
Robertson, J., Peters, M. J., McInnes, I. B., & Sattar, N. (2013) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2013.91 · Cited by 264
Therapeutic Targeting of the Interleukin-6 Receptor
Tanaka, T., Narazaki, M., & Kishimoto, T. (2012) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134715 · Cited by 262
Structure of an Extracellular gp130 Cytokine Receptor Signaling Complex
Chow, D.-C., He, X.-L., Snow, A. L., Rose-John, S., & Garcia, K. C. (2001) · Science · doi:10.1126/science.1058308 · Cited by 261
Self-citationIL-6 Signaling Promotes Tumor Growth in Colorectal Cancer
Becker, C., Fantini, M. C., Wirtz, S., Nikolaev, A., Lehr, H. A., Galle, P. R., John, R., & Neurath, M. F. (2005) · Cell Cycle · doi:10.4161/cc.4.2.1413 · Cited by 255
Dominitzki, S., Fantini, M. C., Neufert, C., Nikolaev, A., Galle, P. R., Scheller, J., Monteleone, G., Rose-John, S., Neurath, M. F., & Becker, C. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.4.2041 · Cited by 227
Self-citationSchultz, O., Oberhauser, F., Saech, J., Rubbert-Roth, A., Hahn, M., Krone, W., & Laudes, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014328 · Cited by 225
Tocilizumab: a novel therapy for patients with large-vessel vasculitis
Salvarani, C., Magnani, L., Catanoso, M., Pipitone, N., Versari, A., Dardani, L., Pulsatelli, L., Meliconi, R., & Boiardi, L. (2012) · Rheumatology · doi:10.1093/rheumatology/ker296 · Cited by 225
Huizinga, T. W. J., Fleischmann, R. M., Jasson, M., Radin, A. R., van Adelsberg, J., Fiore, S., Huang, X., Yancopoulos, G. D., Stahl, N., & Genovese, M. C. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204405 · Cited by 222
Nowell, M. A., Williams, A. S., Carty, S. A., Scheller, J., Hayes, A. J., Jones, G. W., Richards, P. J., Slinn, S., Ernst, M., Jenkins, B. J., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.1.613 · Cited by 215
Self-citationMatsumoto, S., Hara, T., Mitsuyama, K., Yamamoto, M., Tsuruta, O., Sata, M., Scheller, J., Rose-John, S., Kado, S.-I., & Takada, T. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0801217 · Cited by 211
Self-citationHoriuchi, S., Koyanagiu, Y., Zhouu, Y., Miyamotou, H., Tanakau, Y., Waki, M., Matsumoto, A., Yamamotou, M., & Yamamotof, N. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240837 · Cited by 197
Shima, Y., Kuwahara, Y., Murota, H., Kitaba, S., Kawai, M., Hirano, T., Arimitsu, J., Narazaki, M., Hagihara, K., Ogata, A., et al. (2010) · Rheumatology · doi:10.1093/rheumatology/keq275 · Cited by 195
Heterogeneity of human effector CD4+ T cells
Annunziato, F., & Romagnani, S. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2843 · Cited by 194
Sieper, J., Porter-Brown, B., Thompson, L., Harari, O., & Dougados, M. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-203559 · Cited by 184
Klouche, M., Bhakdi, S., Hemmes, M., & Rose-John, S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.8.4583 · Cited by 178
Self-citationIL-6 Controls the Innate Immune Response against Listeria monocytogenes via Classical IL-6 Signaling
Hoge, J., Yan, I., Jänner, N., Schumacher, V., Chalaris, A., Steinmetz, O. M., Engel, D. R., Scheller, J., Rose‐John, S., & Mittrücker, H. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201044 · Cited by 170
Self-citationBarkhausen, T., Tschernig, T., Rosenstiel, P., van Griensven, M., Vonberg, R.-P., Dorsch, M., Mueller-Heine, A., Chalaris, A., Scheller, J., Rose-John, S., et al. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e318211ff56 · Cited by 169
Self-citationCutting Edge: Soluble IL-6R Is Produced by IL-6R Ectodomain Shedding in Activated CD4 T Cells
Briso, E. M., Dienz, O., & Rincon, M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.11.7102 · Cited by 165
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2006
Furst, D. E., Breedveld, F. C., Kalden, J. R., Smolen, J. S., Burmester, G. R., Emery, P., Keystone, E. C., Schiff, M. H., van Riel, P. L. C. M., Weinblatt, M. E., et al. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.061937 · Cited by 159
Audet, J., Miller, C., Rose‐John, S., Piret, J. M., & Eaves, C. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1757 · Cited by 158
Self-citationInterleukin-6--a key mediator of systemic and local symptoms in rheumatoid arthritis.
Cronstein, B. N. (2007) · PubMed · Cited by 152
Neural activities of IL‐6‐type cytokines often depend on soluble cytokine receptors
März, P., Otten, U., & Rose‐John, S. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00755.x · Cited by 147
Self-citationProtein kinase C activity is rate limiting for shedding of the interleukin-6 receptor
Müllberg, J., Schooltink, H., Stoyan, T., Heinrich, P. C., & Rose‐John, S. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)92272-y · Cited by 137
Self-citationRafiq, S., Frayling, T. M., Murray, A., Hurst, A. J., Stevens, K. N., Weedon, M. N., Henley, W., Ferrucci, L., Bandinelli, S., Corsi, A.-M., et al. (2007) · Genes and Immunity · doi:10.1038/sj.gene.6364414 · Cited by 135
Thiolat, A., Semerano, L., Pers, Y., Biton, J., Lemeiter, D., Portalès, P., Quentin, J., Jørgensen, C., Decker, P., Boissier, M., et al. (2013) · Arthritis & Rheumatology · doi:10.1002/art.38246 · Cited by 133
Smolen, J. S., Schoels, M., Nishimoto, N., Breedveld, F. C., Burmester, G. R., Dougados, M., Emery, P., Ferraccioli, G., Gabay, C., Gibofsky, A., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202469 · Cited by 132
STAT3 activation via interleukin 6 trans-signalling contributes to ileitis in SAMP1/Yit mice
Mitsuyama, K., Matsumoto, S., Rose‐John, S., Suzuki, A., Hara, T., Tomiyasu, N., Handa, K., Tsuruta, O., Funabashi, H., Scheller, J., et al. (2006) · Gut · doi:10.1136/gut.2005.079343 · Cited by 130
Self-citationCombined interleukin 6 and soluble interleukin 6 receptor accelerates murine liver regeneration
Peters, M., Blinn, G., Jostock, T., Schirmacher, P., Büschenfelde, K. M. Z., Galle, P. R., & Rose–John, S. (2000) · Gastroenterology · doi:10.1053/gast.2000.20236 · Cited by 129
Self-citationSieper, J., Braun, J., Kay, J., Badalamenti, S., Radin, A. R., Jiao, L., Fiore, S., Momtahen, T., Yancopoulos, G. D., Stahl, N., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204963 · Cited by 127
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2012
Fürst, D. E., Keystone, E. C., So, A. K.-L., Braun, J., Breedveld, F. C., Burmester, G. R., Benedetti, F. D., Dörner, T., Emery, P., Fleischmann, R., et al. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-203348 · Cited by 126
Interleukin-6 as a Therapeutic Target in Candidate Inflammatory Diseases
Nishimoto, N. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2009.313 · Cited by 125
Szepietowski, J. C., Nilganuwong, S., Woźniacka, A. J., Kuhn, A., Nyberg, F., van Vollenhoven, R., Bengtsson, A. A., Reich, A., de Vries, D. E., van Hartingsveldt, B., et al. (2013) · Arthritis & Rheumatism · doi:10.1002/art.38091 · Cited by 121
Interleukin-6: historical background, genetics and biological significance
Wolvekamp, M. C. J., & Marquet, R. L. (1990) · Immunology Letters · doi:10.1016/0165-2478(90)90028-o · Cited by 120
Disease Amelioration With Tocilizumab in a Treatment-Resistant Patient With Neuromyelitis Optica
Kieseier, B. C., Stüve, O., Dehmel, T., Goebels, N., Leussink, V. I., Mausberg, A. K., Ringelstein, M., Turowski, B., Aktaş, O., Antoch, G., et al. (2012) · JAMA Neurology · doi:10.1001/jamaneurol.2013.668 · Cited by 118
Studies on the structure and regulation of the human hepatic interleukin‐6 receptor
Rose‐John, S., Schooltink, H., Lenz, D., Erich, H. I. P. P., Dufhues, G., SCHMITZ, H., Schiel, X., Hirano, T., Kishimoto, T., & Heinrich, P. C. (1990) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1990.tb15548.x · Cited by 107
Self-citationSchoels, M., van der Heijde, D. M. F. M., Breedveld, F. C., Burmester, G. R., Dougados, M., Emery, P., Ferraccioli, G., Gabay, C., Gibofsky, A., Gómez-Reino, J. J., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202470 · Cited by 107
Tocilizumab in rheumatoid arthritis: A meta-analysis of efficacy and selected clinical conundrums
Navarro, G. M., Taroumian, S., Barroso, N., Duan, L., & Furst, D. E. (2013) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2013.08.001 · Cited by 101
Hitting a complex target: an update on interleukin-6 trans-signalling
Waetzig, G. H., & Rose‐John, S. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2012.660307 · Cited by 93
Self-citationThe value of blocking IL-6 outside of rheumatoid arthritis: current perspective
Murakami, M., & Nishimoto, N. (2011) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e3283456797 · Cited by 82
Sodenkamp, J., Waetzig, G. H., Scheller, J., Seegert, D., Grötzinger, J., Rose‐John, S., Ehlers, S., & Hölscher, C. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.01.015 · Cited by 74
Self-citationHyper-IL-6 Gene Therapy Reverses Fulminant Hepatic Failure
Hecht, N., Pappo, O., Shouval, D., Rose‐John, S., Galun, E., & Axelrod, J. H. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0313 · Cited by 72
Self-citationIs Interleukin-6 Receptor Blockade the Holy Grail for Inflammatory Diseases?
Febbraio, M. A., Rose‐John, S., & Pedersen, B. K. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.1 · Cited by 63
Self-citationTocilizumab in the treatment of the adult-onset Still's disease: current clinical evidence
de BOYSSON, H., Février, J., Nicolle, A., Auzary, C., & Geffray, L. (2012) · Clinical Rheumatology · doi:10.1007/s10067-012-2105-2 · Cited by 62
Updating interleukin‐6 classic‐ and trans‐signaling
Scheller, J., Grötzinger, J., & Rose‐John, S. (2006) · Signal Transduction · doi:10.1002/sita.200600086 · Cited by 61
Self-citationTocilizumab Ameliorates Clinical Symptoms in Polymyalgia Rheumatica: Figure 1.
Hagihara, K., Kawase, I., Tanaka, T., & Kishimoto, T. (2010) · The Journal of Rheumatology · doi:10.3899/jrheum.091185 · Cited by 61
The interleukin 6 pathway and atherosclerosis
Scheller, J., & Rose-John, S. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61246-x · Cited by 56
Self-citationTrp53 Deficiency Protects against Acute Intestinal Inflammation
Spehlmann, M. E., Manthey, C., Dann, S. M., Hanson, E. M., Sandhu, S. S., Liu, L. Y., Abdelmalak, F. K., Diamanti, M. A., Retzlaff, K., Scheller, J., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201716 · Cited by 40
Self-citationThe Regenerative Activity of Interleukin-6
Galun, E., & Rose-John, S. (2013) · Methods in Molecular Biology · doi:10.1007/978-1-62703-308-4_4 · Cited by 34
Self-citationHuman Interleukin-6 Facilitates Hepatitis B Virus Infection in Vitro and in Vivo
Galun, E., Nahor, O., Eid, A., Jurim, O., Rose‐John, S., Blum, H. E., Nussbaum, O., Ilan, E., Daudi, N., Shouval, D., et al. (2000) · Virology · doi:10.1006/viro.2000.0210 · Cited by 34
Self-citation
Cited by
Targeting potential drivers of COVID-19: Neutrophil extracellular traps
Barnes, B. J., Adrover, J. M., Baxter-Stoltzfus, A., Borczuk, A., Cools-Lartigue, J., Crawford, J. M., Daßler-Plenker, J., Guerci, P., Huynh, C., Knight, J. S., et al. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20200652 · Cited by 1,486
JAK inhibition as a therapeutic strategy for immune and inflammatory diseases
Schwartz, D. M., Kanno, Y., Villarino, A., Ward, M., Gadina, M., & O'Shea, J. J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.201 · Cited by 1,266
Fever and the thermal regulation of immunity: the immune system feels the heat
Evans, S. S., Repasky, E. A., & Fisher, D. T. (2015) · Nature Reviews Immunology · doi:10.1038/nri3843 · Cited by 1,257
Teachey, D. T., Lacey, S. F., Shaw, P. A., Melenhorst, J. J., Maude, S. L., Frey, N., Pequignot, E., Gonzalez, V. E., Chen, F., Finklestein, J., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0040 · Cited by 1,102
Self-citationIL-6 pathway in the liver: From physiopathology to therapy
Schmidt-Arras, D., & Rose-John, S. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.02.004 · Cited by 881
Self-citation
Metadata
- Authors
- Calabrese, L. H., & Rose-John, S.
- Venue
- Nature Reviews Rheumatology
- Published
- 2014-08-19
- Volume
- 10
- Issue
- 12
- Pages
- 720-727
- ISSN
- 1759-4790 (ISSN-L)
- 1759-4804
- OpenAlex
- W2098776090
- Cited by
- 328
- References
- 94
- FWCI
- 3.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.